Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jun 15;30(13):1608-17.
doi: 10.1002/sim.4132. Epub 2011 Feb 22.

Estimating and testing for center effects in competing risks

Affiliations
Comparative Study

Estimating and testing for center effects in competing risks

Sandrine Katsahian et al. Stat Med. .

Abstract

The problems of fitting Gaussian frailties proportional hazards models for the subdistribution of a competing risk and of testing for center effects are considered. In the analysis of competing risks data, Fine and Gray proposed a proportional hazards model for the subdistribution to directly assess the effects of covariates on the marginal failure probabilities of a given failure cause. Katsahianbiet al. extended their model to clustered time to event data, by including random center effects or frailties in the subdistribution hazard. We first introduce an alternate estimation procedure to the one proposed by Katsahian et al. This alternate estimation method is based on the penalized partial likelihood approach often used in fitting Gaussian frailty proportional hazards models in the standard survival analysis context, and has the advantage of using standard survival analysis software. Second, four hypothesis tests for the presence of center effects are given and compared via Monte-Carlo simulations. Statistical and numerical considerations lead us to formulate pragmatic guidelines as to which of the four tests is preferable. We also illustrate the proposed methodology with registry data from bone marrow transplantation for acute myeloid leukemia (AML).

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms